Who Owns TransCode Therapeutics, Inc. (RNAZ)?Hedge Fund & Institutional Holders
Institutional Holders
8
as of Q4 2025
Total Institutional Value
$190.0T
% of Float Held
—
QoQ Change in Holders
+2 / -4
Price History
RNAZ — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| UBS Group AG | New Position | +3K | +$19.0M |
| SBI Securities Co., Ltd. | New Position | +10 | +$0 |
| Tower Research Capital LLC (TRC) | Increased | +745 | +$-1.5M |
RNAZ — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| DRW Securities, LLC | Closed Position | -12K | -$125.8M |
| CITIGROUP INC | Closed Position | -2K | -$17.0M |
| Federation des caisses Desjardins du Quebec | Closed Position | -975 | -$10K |
| DANSKE BANK A/S | Closed Position | -1 | -$0 |
Top Institutional Holders(Q4 2025)
| # | Fund | Shares | Value | % of Portfolio | Type |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 2,885 | $19.0M | 0.00% | Share |
| 2 | ROYAL BANK OF CANADA | 8 | $0 | 0.00% | Share |
| 3 | UBS Group AG | 79 | $0 | 0.00% | Share |
| 4 | Tower Research Capital LLC (TRC) | 887 | $0 | 0.00% | Share |
| 5 | BANK OF AMERICA CORP /DE/ | 7 | $0 | 0.00% | Share |
| 6 | BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% | Share |
| 7 | OSAIC HOLDINGS, INC. | 3 | $0 | 0.00% | Share |
| 8 | SBI Securities Co., Ltd. | 10 | $0 | 0.00% | Share |
RNAZ Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 6 | $19.0M | -2 |
| Q3 2025 | 8 | $144.3M | +0 |
| Q2 2025 | 8 | $18.1M | -9 |
| Q1 2025 | 17 | $1.0B | +12 |
| Q4 2024 | 5 | $32.4M | -5 |
| Q3 2024 | 10 | $22.7B | -3 |
| Q2 2024 | 13 | $143.3M | +8 |
| Q1 2024 | 5 | $3.4M | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 8 institutional investors hold RNAZ (TransCode Therapeutics, Inc.). The largest holder is UBS Group AG with $19.0M in shares. This quarter, 2 institutions opened new positions and 4 closed their positions.
Frequently Asked Questions
How many hedge funds own RNAZ?
As of Q4 2025, 8 institutional investors report holding RNAZ (TransCode Therapeutics, Inc.) in their 13F filings.
Who is the largest institutional holder of RNAZ?
The largest institutional holder of RNAZ is UBS Group AG with $19.0M in shares.
Is institutional ownership of RNAZ increasing or decreasing?
This quarter, 2 institutions opened new positions in RNAZ and 4 closed their positions.